ESGCT annual congress is considered as the more relevant event in Europe related to Advanced Therapies.

VIVEbiotech as an expert in Lentiviral vector manufacture will have the opportunity to meet with different Companies and Applied research institutions about its CDMO services and about Lentisoma technology.

Specifically, Juan Carlos Ramirez, Chief Technology/Scientific Officer and Natalia Elizalde, Business Development Director, will participate.

We will be very pleased to organize a meeting with you at this event.